⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for seborrheic keratosis

Every month we try and update this database with for seborrheic keratosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of A-101 for the Treatment of Seborrheic KeratosisNCT02260180
Seborrheic Kera...
A-101
18 Years - 75 YearsAclaris Therapeutics, Inc.
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis StudyNCT03846531
Lesion Skin
Seborrheic Kera...
Nano-Pulse Stim...
18 Years - 75 YearsPulse Biosciences, Inc.
An Open-Label Safety Study of A-101 SolutionNCT02667288
Seborrheic Kera...
A-101 Solution
18 Years - Aclaris Therapeutics, Inc.
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization StudyNCT04249115
Lesion Skin
Seborrheic Kera...
Skin Lesion
Benign Skin Tum...
Nano-Pulse Stim...
21 Years - 75 YearsPulse Biosciences, Inc.
Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic KeratosisNCT05136144
Seborrheic Kera...
SM-020
18 Years - DermBiont, Inc.
Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic KeratosisNCT01214564
Seborrheic Kera...
PEP005 (ingenol...
18 Years - Peplin
Fast Track Diagnosis of Skin Cancer by Advanced ImagingNCT04229277
Malignant Melan...
Nevus, Pigmente...
Basal Cell Carc...
Seborrheic Kera...
optical coheren...
18 Years - University Hospital Bispebjerg and Frederiksberg
Optical Biopsy of Human Skin in Conjunction With Laser TreatmentNCT00540566
Malignant Melan...
Merkel Cell Car...
Basal Cell Carc...
Squamous Cell C...
Atypical Nevi
Congenital Nevi
Seborrheic Kera...
Paget's Disease
Dermatofibroma
Kaposi's Sarcom...
Port Wine Stain
Hemangioma
Tattoos
Scleroderma
Burns
Optical Biopsy ...
18 Years - 75 YearsUniversity of California, Irvine
Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?NCT01159860
Seborrheic Kera...
cryosurgery
Curettage
18 Years - 75 YearsMilton S. Hershey Medical Center
Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented TumorsNCT06046144
Basal Cell Carc...
Lentigo Maligna
Melanoma
Nevus
Seborrheic Kera...
Lentigo
Fluorescence-Ad...
Reflectance con...
Super-high magn...
- Centre Hospitalier Universitaire de Saint Etienne
A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic KeratosisNCT03148691
Seborrheic Kera...
A-101
18 Years - Aclaris Therapeutics, Inc.
Dose-Response Profile of A-101 in Subjects With Seborrheic KeratosisNCT02160626
Seborrheic Kera...
A-101 Vehicle
A-101 (40) Topi...
A-101 (32.5) To...
18 Years - Aclaris Therapeutics, Inc.
Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin DamageNCT04688749
Melanoma (Skin)
Basal Cell Carc...
Squamous Cell C...
Dysplastic Nevu...
Lentigo Maligna
Seborrheic Kera...
Lichen Planus-L...
Carcinosarcoma
Electrical Impe...
8 Years - 90 YearsAristotle University Of Thessaloniki
Study of A-101 for the Treatment of Seborrheic KeratosisNCT02260180
Seborrheic Kera...
A-101
18 Years - 75 YearsAclaris Therapeutics, Inc.
Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic KeratosisNCT05136144
Seborrheic Kera...
SM-020
18 Years - DermBiont, Inc.
A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic KeratosisNCT02667275
Seborrheic Kera...
A-101 Solution
Vehicle Solutio...
18 Years - Aclaris Therapeutics, Inc.
A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.NCT02667236
Seborrheic Kera...
A-101 Solution
Vehicle Solutio...
18 Years - Aclaris Therapeutics, Inc.
Fast Track Diagnosis of Skin Cancer by Advanced ImagingNCT04229277
Malignant Melan...
Nevus, Pigmente...
Basal Cell Carc...
Seborrheic Kera...
optical coheren...
18 Years - University Hospital Bispebjerg and Frederiksberg
Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented TumorsNCT06046144
Basal Cell Carc...
Lentigo Maligna
Melanoma
Nevus
Seborrheic Kera...
Lentigo
Fluorescence-Ad...
Reflectance con...
Super-high magn...
- Centre Hospitalier Universitaire de Saint Etienne
Dose-Response Profile of A-101 in Subjects With Seborrheic KeratosisNCT02160626
Seborrheic Kera...
A-101 Vehicle
A-101 (40) Topi...
A-101 (32.5) To...
18 Years - Aclaris Therapeutics, Inc.
Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic KeratosisNCT01986920
Seborrheic Kera...
A-101 25%
A-101 32.5%
A-101 40%
A-101 Vehicle
18 Years - Aclaris Therapeutics, Inc.
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic KeratosesNCT03487588
Seborrheic Kera...
A-101 Topical S...
30 Years - 75 YearsAclaris Therapeutics, Inc.
Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin DamageNCT04688749
Melanoma (Skin)
Basal Cell Carc...
Squamous Cell C...
Dysplastic Nevu...
Lentigo Maligna
Seborrheic Kera...
Lichen Planus-L...
Carcinosarcoma
Electrical Impe...
8 Years - 90 YearsAristotle University Of Thessaloniki
A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.NCT02667236
Seborrheic Kera...
A-101 Solution
Vehicle Solutio...
18 Years - Aclaris Therapeutics, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: